Stock code

SSE: 603127
HKEX: 06127
Drug Abuse & Dependence

JOINN has filed the most amounts of carcinogenicity study data to the Chinese NMPA and US FDA among all other Chinese CROs. Protocols for carcinogenicity studies are designed according to the government oversight guidelines (NMPA, FDA, ICH, EPA, OECD and EU) and are conducted in full compliance with GLP standards. We have veteran pathological diagnostic team and abundant historical database of carcinogenicity studies. JOINN has established credibility and excellent track record of acceptance of the carcinogenicity study data by USFDA and Chinese NMPA.

GLP Services

Autonomous Administration Test

Conditioned Place Preference/Aversion

Behavioral Sensitization Test

Drug Identification Test

Natural Withdrawal Test

Urgent Withdrawal Test

Administration Route

Except for the autonomous drug administration trial, which is only suitable for intravenous drug administration, other trial items can be suitable for oral, subcutaneous, muscular, intravenous, abdominal, and local drug administration, etc.